SIREN : 489798884
JALUBE MEDICAL is a French company founded 20 years ago, specialized in the sector Réparation de matériels électroniques et optiques. Based in PARON (89100), this company of category PME shows in 2016 a revenue of 660 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2016 |
|---|---|---|
| Revenue | N/C | 660 212 € |
| Net income | 9 886 € | 8 079 € |
| EBITDA | N/C | 24 656 € |
| Net margin | N/C | 1.2% |
In 2025, JALUBE MEDICAL generates positive net income of 10 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 8 k€ -> 10 k€.
9 886 €
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
24.341%
57.989%
58.1%
In 2025, the debt ratio of JALUBE MEDICAL (24.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of JALUBE MEDICAL (58.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2016, the repayment capacity of JALUBE MEDICAL (0.03) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 229.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
229.977
In 2025, the liquidity ratio of JALUBE MEDICAL (229.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2016, the interest coverage of JALUBE MEDICAL (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 197 transactions of similar company sales (all years), the value of JALUBE MEDICAL is estimated at 19 965 € (range 8 409€ - 52 330€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 197 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare JALUBE MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Réparation de matériels électroniques et optiques
The revenue of JALUBE MEDICAL in 2016 is 660 k€.
Yes, JALUBE MEDICAL generated a net profit of 10 k€ in 2025.
The headquarters of JALUBE MEDICAL is located in PARON (89100), in the department Yonne.
The tax return of JALUBE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
JALUBE MEDICAL operates in the sector Réparation de matériels électroniques et optiques (NAF code 33.13Z). See the 'Sector positioning' section above to compare the company with its competitors.